Paper Review Records
All Paper Review Records
16 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
204
days
National statement of clinical and therapeutic approach of patients with systemic sclerosis-associated interstitial lung disease in Belgium on behalf of the Flemish network on rare connective tissue diseases
Authors
J. Guiot; A.N Frix; N. Aerts; S. Ajeganova; B. André; C. Belge; D. Blockmans; B. Bondue; G. Brusselle; C. Dahlqvist; R. De Bruyne; C. De Cock; M. De Decker; E. Degraeuwe; P. De Haes; E. De Langhe; F. Demolder; A. Depicker; E. Docampo; T. Du Four; F. Dujardin; C. Frank; A. Froidure; F. Gester; J. Goubau; N. Gusbin; I. Hennes; I. Hoffman; J. Lenaerts; M. Leys; R. Louis; K. Melsens; A. Moeyersoons; M. Petrovic; Y. Piette; K. Polfliet; T. Renson; C. Ribbens; D. Ruttens; H. Slabbynck; K. Thevissen; D. Van Assche; E. Vandecasteele; M. Van Mechelen; G.R. Van Pottelberge; M. Vanthuyne; I. Vos; R. Westhovens; G. Wirtz; W. A. Wuyts; V. SmithShow moreShow less
Affiliations
1. University Hospital (CHU) of Liège; 2. University of Liège; 3. Avenue Pasteur 6; 4. Ziekenhuis Aan de Stroom; 5. Université Libre de Bruxelles; 6. University Hospitals of Leuven; 7. KU Leuven-University of Leuven; 8. University Hospitals Leuven; 9. Immunology, and Transplantation, KU; 10. Hopital Erasme; 11. Ghent University Hospital; 12. CHU UCL Namur; 13. Ghent University; 14. Maria Middelares; 15. Department of Development and regeneration, KU Leuven, Leuven; 16. Vrije Universiteit Brussel (VUB); 17. Chairman Eds.Vlaanderen, Global Alliance Member Ehlers - Danlos Society; 18. Flemish Association for Hereditary Connective Tissue Disorders; 19. Saint-Luc Universitary Hospital, UCLouvain; 20. AZ Maria Middelares; 21. UZ; 22. CHR Citadelle; 23. Patiëntexpert ReumaNet, CIB-Liga; 24. Department of Rheumatology, Reuma institute and Jessa hospital; 25. AZ Groeninge; 26. Vitaz; 27. AZ Sint-Jan Brugge AV; 28. Patiëntexpert ReumaNet, Sclero’ken VZW; 29. Ziekenhuis Oost; 30. Hasselt University; 31. Faculty of Movement and Rehabilitation Sciences, KU; 32. Allergology and Rheumatology, University Hospital Antwerp; 33. Cliniques universitaires; 34. CHU; 35. Centre Hospitalier du Luxembourg; 36. Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE) KU; 37. VIB Inflammation Research Centre (IRC)Show moreShow less
111
days
Recent trial evidence supports enhanced influenza vaccines for older adults: implications for Belgian practice
Authors
Steven Callens; Michael Peeters; Yves Van LaethemShow moreShow less
Affiliations
1. Ghent University Hospital (UZ Gent); 2. Ghent University (UGent); 3. Food Chain Safety and EnvironmentShow moreShow less
157
days
Polish validation of the Simpler Modified Fried Frailty Scale for frailty screening in older inpatients
Authors
Fatma Ozge Kayhan Kocak; Karolina Piotrowicz; Tuğba Erdoğan; Jerzy Gąsowski; Joanna Czesak; Zeynep Fetullahoğlu; Mehmet Akif Karan; Gülistan BahatShow moreShow less
Affiliations
1. Health Science University; 2. Jagiellonian University Medical College; 3. Istanbul University; 4. University School of Physical EducationShow moreShow less
126
days
Evaluation of the predictive performance of CD64 and CD69 markers in the early diagnosis of bloodstream infections
Authors
Göksel Bilir; Mümtaz Cem Şirin; Emel Sesli Çetin; Buket ArıdoğanShow moreShow less
Affiliations
1. Suleyman Demirel UniversityShow moreShow less
50
days
Pitfalls in the diagnosis of diffuse large B-cell lymphoma with flow cytometry
Authors
Victor Pas; Mattias Hofmans; Stijn LambrechtShow moreShow less
Affiliations
1. Ghent University Hospital; 2. Ghent UniversityShow moreShow less
205
days
CAR T-cell therapy for relapsed and refractory B-cell non-Hodgkin lymphoma: a single-centre 5-year real-world experience study at Ghent University Hospital
Authors
Julie Vandewiele; Chiel Gharakhani; Ciel De Vriendt; Willem DaneelsShow moreShow less
Affiliations
1. UZ Gent; 2. Ghent University Hospital; 3. Ghent UniversityShow moreShow less
FAQ
How long does ACTA CLINICA BELGICA take to review a manuscript?
As of 2026-11-19, CrushSCI has 16 complete review records for ACTA CLINICA BELGICA. The fastest paper went from submission to acceptance in 37 days (Obinutuzumab for membranous nephropathy: a systematic review using pooled case-level extraction analysis, received 2026-01-22, accepted 2026-02-28); the slowest took 205 days. The average is 104.2 days and the median is 92.5 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
